Early increase in PD-L1 expression is associated with response to treatment. Analysis of longitudinal biopsies in patients treated with PD-1 inhibitors revealed that an increase in PD-L1 expression compared to baseline in the first eight weeks of therapy correlated with an increase in tumor-infiltrating T-cells and was an indicator of a treatment response [162,163]. The gene discussed is CD274; the disease is neoplasm.